These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 34292795)
1. Therapeutic challenges at the preclinical level for targeted drug development for Loilome W; Dokduang H; Suksawat M; Padthaisong S Expert Opin Investig Drugs; 2021 Sep; 30(9):985-1006. PubMed ID: 34292795 [TBL] [Abstract][Full Text] [Related]
2. Protein Kinases as Targets for Opisthorchis viverrini- Associated Cholangiocarcinoma Therapy. Loilome W; Dokduang H Curr Pharm Des; 2017 Nov; 23(29):4281-4289. PubMed ID: 28699535 [TBL] [Abstract][Full Text] [Related]
3. Druggable molecular alterations in bile duct cancer: potential and current therapeutic applications in clinical trials. Bourien H; Lamarca A; McNamara MG; Hubner RA; Valle JW; Edeline J Expert Opin Investig Drugs; 2021 Sep; 30(9):975-983. PubMed ID: 34420429 [No Abstract] [Full Text] [Related]
4. microRNA profiling of exosomes derived from plasma and their potential as biomarkers for Opisthorchis viverrini-associated cholangiocarcinoma. Supradit K; Wongprasert K; Tangphatsornruang S; Yoocha T; Sonthirod C; Pootakham W; Thitapakorn V; Butthongkomvong K; Phanaksri T; Kunjantarachot A; Klongprateeppon H; Sattavacharavech P; Prasopdee S Acta Trop; 2024 Oct; 258():107362. PubMed ID: 39151716 [TBL] [Abstract][Full Text] [Related]
5. Wound healing and cancer progression in Opisthorchis viverrini associated cholangiocarcinoma. Botelho MC; Alves H; Richter J Parasitol Res; 2016 Jul; 115(7):2913-4. PubMed ID: 27130317 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma. Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692 [TBL] [Abstract][Full Text] [Related]
8. Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study. Chansitthichok S; Chamnan P; Sarkhampee P; Lertsawatvicha N; Voravisutthikul P; Wattanarath P Asian Pac J Cancer Prev; 2020 Apr; 21(4):903-909. PubMed ID: 32334449 [TBL] [Abstract][Full Text] [Related]
9. Banking on the future: biobanking for "omics" approaches to biomarker discovery for Opisthorchis-induced cholangiocarcinoma in Thailand. Mulvenna J; Yonglitthipagon P; Sripa B; Brindley PJ; Loukas A; Bethony JM Parasitol Int; 2012 Mar; 61(1):173-7. PubMed ID: 21855650 [TBL] [Abstract][Full Text] [Related]
10. MTHFR polymorphisms and Opisthorchis viverrini infection: a relationship with increased susceptibility to cholangiocarcinoma in Thailand. Songserm N; Promthet S; Sithithaworn P; Pientong C; Ekalaksananan T; Chopjitt P; Parkin DM Asian Pac J Cancer Prev; 2011; 12(5):1341-5. PubMed ID: 21875294 [TBL] [Abstract][Full Text] [Related]
11. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention]. Buisson Y Bull Soc Pathol Exot; 2017 Feb; 110(1):61-67. PubMed ID: 28105582 [TBL] [Abstract][Full Text] [Related]
12. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma. Yongvanit P; Pinlaor S; Loilome W J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859 [TBL] [Abstract][Full Text] [Related]
13. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954 [No Abstract] [Full Text] [Related]
15. A combination of liver fluke infection and traditional northeastern Thai foods associated with cholangiocarcinoma development. Sriraj P; Boonmars T; Aukkanimart R; Songsri J; Sripan P; Ratanasuwan P; Boonjaraspinyo S; Wongchalee N; Laummaunwai P Parasitol Res; 2016 Oct; 115(10):3843-52. PubMed ID: 27271702 [TBL] [Abstract][Full Text] [Related]
16. Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma. Wu Z; Boonmars T; Nagano I; Boonjaraspinyo S; Srinontong P; Ratasuwan P; Narong K; Nielsen PS; Maekawa Y Int J Cancer; 2016 Jan; 138(2):396-408. PubMed ID: 26312563 [TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma. Saengboonmee C; Seubwai W; Wongkham C; Wongkham S Cancer Epidemiol; 2015 Jun; 39(3):274-8. PubMed ID: 25910864 [TBL] [Abstract][Full Text] [Related]
18. A combination of praziquantel and the traditional medicinal plant Thunbergia laurifolia on Opisthorchis viverrini infection and cholangiocarcinoma in a hamster model. Wonkchalee N; Boonmars T; Laummaunwai P; Aromdee C; Hahnvajanawong C; Wu Z; Sriraj P; Aukkanimart R; Chamgramol Y; Pairojkul C; Juasook A; Sudsarn P Parasitol Res; 2013 Dec; 112(12):4211-9. PubMed ID: 24057695 [TBL] [Abstract][Full Text] [Related]
19. Viable metacercariae of Opisthorchis viverrini in northeastern Thai cyprinid fish dishes--as part of a rational program for control of O. viverrini-associated cholangiocarcinoma. Prasongwatana J; Laummaunwai P; Boonmars T; Pinlaor S Parasitol Res; 2013 Mar; 112(3):1323-7. PubMed ID: 23052784 [TBL] [Abstract][Full Text] [Related]
20. Ultrasonographic features of hepatobiliary pathology in opisthorchiasis and opisthorchiasis-associated cholangiocarcinoma. Mairiang E Parasitol Int; 2017 Aug; 66(4):378-382. PubMed ID: 27956092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]